Delivery Order SPE2DB20D1051-SPE2DB24FD7QD

Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $2,203.21 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide IMIQUIMOD 5% CREAM PACKET 24S. The contract has an ultimate completion date of February 20, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Imiquimod 3.75% Cream Pump, 7.5 gm. The order, valued at $1,302.82, has a completion date of March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Imiquimod 5% Cream Packets. The order has a ceiling value of $10,479.63 and is a firm fixed-price contract. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a wide range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,959.25, is for the delivery of IMIQUIMOD 5% cream packets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of February 11, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Imiquimod 3.75% cream in 28-count packages, with a ceiling value of $17,482.59 and a period of performance through April 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to fulfill government contracts, particularly for the Department...
This federal contract award to AmerisourceBergen Drug Corp provides for the delivery of Imiquimod 5% cream packets to support Defense Logistics Agency (DLA) Troop Support Medical. The $8,009.73 Firm Fixed Price contract has an ultimate completion date of December 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA to provide a broad range of pharmaceutical products and medical supplies to...
This contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of Imiquimod 5% cream packets. The fixed-price delivery order, valued at $1,109.32, was issued by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
The Defense Logistics Agency awarded a $80,920 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IMIQUIMOD 5% cream packets. As the prime contractor, Amerisourcebergen will deliver 24 packets of the prescribed cream to an address in Conshohocken, Pennsylvania by September 28, 2023 to fulfill requirements under the contract. The contract was awarded utilizing the DLA's indefinite-delivery/indefinite-quantity federal supply schedule, which provides government agencies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Imiquimod 3.75% Cream Pump, 7.5 gm. The $3,193.43 firm fixed-price contract has an ultimate completion date of April 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA)...
This federal contract award, valued at $6,103.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMIQUIMOD 5% CREAM PACKET 24S, a medical product, with a completion date of June 22, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB24FD7QD
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Imiquimod 5% cream packets. The $2,309.30 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025 to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation.

Generated 7/5/24, 9:19 AM